Treatment with encapsulated Hsp60 peptide (p277) prolongs skin graft survival in a murine model of minor antigen disparity

Scandinavian Journal of Immunology

Volumn 66, Issue 1, 2007, Pages 62-70

  Luna, E ^a   Postol, E ^a   Caldas, C ^a   Benvenuti, L A ^a   Rodrigues Jr , J M ^c   Lima, K ^c   Kalil, J ^a,b   Coelho, V ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Millennium Institute   (Brazil)

^c NANOCORE Biotecnologia Ltda   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65 P 277 PEPTIDE; INTERLEUKIN 10; PEPTIDE; POLYGLACTIN; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG COATING; ENCAPSULATION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; INTERFERON PRODUCTION; MALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; SKIN GRAFT REJECTION; SKIN TRANSPLANTATION; THERAPY EFFECT; TREATMENT RESPONSE;

EID: 34250891852     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01951.x     Document Type: Article

References (59)

1. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet 1988 22 : 631 77.
2. Jones DB, Coulson AF, Duff GW. Sequence homologies between hsp60 and autoantigens. Immunol Today 1993 14 : 115 8.
3. Gaston JS, Life PF, Jenner PJ, Colston MJ, Bacon PA. Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J Exp Med 1990 171 : 831 41.
4. Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A 1990 87 : 1576 80.
5. Elias D, Cohen IR. Peptide therapy for diabetes in NOD mice. Lancet 1994 343 : 704 6.
6. Birk OS, Elias D, Weiss AS et al. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. J Autoimmun 1996 9 : 159 66.
7. Maron R, Sukhova G, Faria AM et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002 106 : 1708 15.
8. Phipps PA, Stanford MR, Sun JB et al. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur J Immunol 2003 33 : 224 32.
9. de Kleer IM, Kamphuis SM, Rijkers GT et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 2003 48 : 2001 10.
10. van Roon JA, van Eden W, van Roy JL, Lafeber FJ, Bijlsma JW. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1997 100 : 459 63.
11. Cohen IR. Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination. Diabetologia 2002 45 : 1468 74.
12. Stanford M, Whittall T, Bergmeier LA et al. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin Exp Immunol 2004 137 : 201 8.
13. Schwartz M, Cohen IR. Autoimmunity can benefit self-maintenance. Immunol Today 2000 21 : 265 8.
14. Cohen IR. Discrimination and dialogue in the immune system. Semin Immunol 2000 12 : 215 9 discussion 257-344.
15. Kumar R, Perdrizet G, Enderle J, Rewinski M, Berman M, Hightower L. Stress proteins are proinflammatory in vivo. IEEE Eng Med Biol Mag 2004 23 : 80 4.
16. Moliterno R, Valdivia L, Pan F, Duquesnoy RJ. Heat shock protein reactivity of lymphocytes isolated from heterotopic rat cardiac allografts. Transplantation 1995 59 : 598 604.
17. Granja C, Moliterno RA, Ferreira MS, Fonseca JA, Kalil J, Coelho V. T-cell autoreactivity to Hsp in human transplantation may involve both proinflammatory and regulatory functions. Hum Immunol 2004 65 : 124 34.
18. Matsunaga Y, Wakatsuki Y, Tabata Y et al. Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization. Vaccine 2000 19 : 579 88.
19. Birk OS, Gur SL, Elias D et al. The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci U S A 1999 96 : 5159 63.
20. Chai JG, James E, Dewchand H, Simpson E, Scott D. Transplantation tolerance induced by intranasal administration of HY peptides. Blood 2004 103 : 3951 9.
21. Caldas C, Luna E, Spadafora-Ferreira M et al. Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses. Clin Exp Immunol 2006 146 : 66 75.
22. Aida Y, Pabst MJ. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods 1990 132 : 191 5.
23. Billingham RE, Brent L, Medawar PB, Sparrow EM. Quantitative studies on tissue transplantation immunity. I. The survival times of skin homografts exchanged between members of different inbred strains of mice. Proc R Soc Lond B Biol Sci 1954 143 : 43 58.
24. Dettino AL, Duarte AJ, Sato MN. Induction of oral tolerance and the effect of interleukin-4 on murine skin allograft rejection. Braz J Med Biol Res 2004 37 : 435 40.
25. Lu X, Zhou L, Chen S. Prolongation of skin allograft survival by combined feeding of donor spleen cells and cyclosporine in mice. Transplant Proc 2004 36 : 2429 31.
26. Van Eden W, Van Der Zee R, Van Kooten P et al. Balancing the immune system: Th1 and Th2. Ann Rheum Dis 2002 61 (Suppl. 2 ii25 8.
27. Moliterno R, Woan M, Bentlejewski C et al. Heat shock protein-induced T-lymphocyte propagation from endomyocardial biopsies in heart transplantation. J Heart Lung Transplant 1995 14 : 329 37.
28. Kaufmann SH. Heat shock proteins and the immune response. Immunol Today 1990 11 : 129 36.
29. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994 265 : 1237 40.
30. Samsom JN. Regulation of antigen-specific regulatory T-cell induction via nasal and oral mucosa. Crit Rev Immunol 2004 24 : 157 77.
31. Benichou G, Tam RC, Soares LR, Fedoseyeva EV. Indirect T-cell allorecognition: perspectives for peptide-based therapy in transplantation. Immunol Today 1997 18 : 67 71.
32. Marrero I, Benvenutti LA, Kalil J, Coelho V. Autoreactivity to self H-2Kb peptides in TAP1 mice. Intravenous administration of H-2Kb class I-derived peptides induces long-term survival of grafts from C57BL/6 donors. Immunology 2005 115 : 484 94.
33. Fedoseyeva EV, Kishimoto K, Rolls HK et al. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol 2002 169 : 1168 74.
34. Song Y, Wang Y, Thakur R, Meidan VM, Michniak B. Mucosal drug delivery: membranes, methodologies, and applications. Crit Rev Ther Drug Carrier Syst 2004 21 : 195 256.
35. Wang H, Hosiawa KA, Min W et al. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J Immunol 2003 171 : 3823 36.
36. Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 2001 358 : 1749 53.
37. Raz I, Avron A, Tamir M et al. Treatment of new-onset type 1 diabetes with peptide DiaPep277((R)) is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial. Diabetes Metab Res Rev 2007 23 : 292 8.
38. Huurman VA, Decochez K, Mathieu C, Cohen IR, Roep BO. Therapy with the hsp60 peptide DiaPep277(trade mark) in C-peptide positive type 1 diabetes patients. Diabetes Metab Res Rev 2007 23 : 269 75.
39. Lazar L, Ofan R, Weintrob N et al. Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study. Diabetes Metab Res Rev 2007 23 : 286 91.
40. Elias D, Meilin A, Ablamunits V et al. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes 1997 46 : 758 64.
41. Durai M, Gupta RS, Moudgil KD. The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis. J Immunol 2004 172 : 2795 802.
42. Feili-Hariri M, Frantz MO, Morel PA. Prevention of diabetes in the NOD mouse by a Th1 clone specific for a hsp60 peptide. J Autoimmun 2000 14 : 133 42.
43. Paul AG, van Kooten PJ, van Eden W, van der Zee R. Highly autoproliferative T cells specific for 60-kDa heat shock protein produce IL-4/IL-10 and IFN-gamma and are protective in adjuvant arthritis. J Immunol 2000 165 : 7270 7.
44. Paul AG, van der Zee R, Taams LS, van Eden W. A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis? Int Immunol 2000 12 : 1041 50.
45. Habich C, Kempe K, van der Zee R et al. Heat shock protein 60: specific binding of lipopolysaccharide. J Immunol 2005 174 : 1298 305.
46. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994 12 : 991 1045.
47. Chen W, Syldath U, Bellmann K, Burkart V, Kolb H. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 1999 162 : 3212 9.
48. Flohe SB, Bruggemann J, Lendemans S et al. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol 2003 170 : 2340 8.
49. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000 164 : 558 61.
50. Zanin-Zhorov A, Nussbaum G, Franitza S, Cohen IR, Lider O. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J 2003 17 : 1567 9.
51. Gao B, Tsan MF. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J Biol Chem 2003 278 : 22523 9.
52. Osterloh A, Meier-Stiegen F, Veit A, Fleischer B, von Bonin A, Breloer M. Lipopolysaccharide-free heat shock protein 60 activates T cells. J Biol Chem 2004 279 : 47906 11.
53. Zanin-Zhorov A, Bruck R, Tal G et al. Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J Immunol 2005 174 : 3227 36.
54. Zanin-Zhorov A, Tal G, Shivtiel S et al. Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: effects on signaling, chemotaxis, and inflammation. J Immunol 2005 175 : 276 85.
55. Zanin-Zhorov A, Cahalon L, Tal G, Margalit R, Lider O, Cohen IR. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 2006 116 : 2022 32.
56. Cohen-Sfady M, Nussbaum G, Pevsner-Fischer M et al. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol 2005 175 : 3594 602.
57. Caldas C, Spadafora-Ferreira M, Fonseca JA et al. T-cell response to self HSP60 peptides in renal transplant recipients: a regulatory role? Transplant Proc 2004 36 : 833 5.
58. Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB. The balance of deletion and regulation in allograft tolerance. Immunol Rev 2003 196 : 75 84.
59. Lechler RI, Garden OA, Turka LA. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003 3 : 147 58.